310 related articles for article (PubMed ID: 20380543)
1. Indirubin potentiates ciprofloxacin activity in the NorA efflux pump of Staphylococcus aureus.
Ponnusamy K; Ramasamy M; Savarimuthu I; Paulraj MG
Scand J Infect Dis; 2010 Jul; 42(6-7):500-5. PubMed ID: 20380543
[TBL] [Abstract][Full Text] [Related]
2. Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees.
Holler JG; Christensen SB; Slotved HC; Rasmussen HB; Gúzman A; Olsen CE; Petersen B; Mølgaard P
J Antimicrob Chemother; 2012 May; 67(5):1138-44. PubMed ID: 22311936
[TBL] [Abstract][Full Text] [Related]
3. Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles.
Holler JG; Slotved HC; Mølgaard P; Olsen CE; Christensen SB
Bioorg Med Chem; 2012 Jul; 20(14):4514-21. PubMed ID: 22682300
[TBL] [Abstract][Full Text] [Related]
4. Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.
Kalia NP; Mahajan P; Mehra R; Nargotra A; Sharma JP; Koul S; Khan IA
J Antimicrob Chemother; 2012 Oct; 67(10):2401-8. PubMed ID: 22807321
[TBL] [Abstract][Full Text] [Related]
5. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
Kumar A; Khan IA; Koul S; Koul JL; Taneja SC; Ali I; Ali F; Sharma S; Mirza ZM; Kumar M; Sangwan PL; Gupta P; Thota N; Qazi GN
J Antimicrob Chemother; 2008 Jun; 61(6):1270-6. PubMed ID: 18334493
[TBL] [Abstract][Full Text] [Related]
6. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
[TBL] [Abstract][Full Text] [Related]
7. NorA efflux pump inhibitory activity of coumarins from Mesua ferrea.
Roy SK; Kumari N; Pahwa S; Agrahari UC; Bhutani KK; Jachak SM; Nandanwar H
Fitoterapia; 2013 Oct; 90():140-50. PubMed ID: 23892000
[TBL] [Abstract][Full Text] [Related]
8. Unlocking bacterial defense: Exploring the potent inhibition of NorA efflux pump by coumarin derivatives in Staphylococcus aureus.
Martin ALAR; Pereira RLS; Rocha JE; Farias PAM; Freitas TS; Caldas FRL; Figueredo FG; Sampaio NFL; Oliveira-Tintino CDM; Tintino SR; da Hora GCA; Lima MCP; de Menezes IRA; Carvalho DT; Coutinho HDM; Fonteles MMF
Microb Pathog; 2024 May; 190():106608. PubMed ID: 38503396
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
[TBL] [Abstract][Full Text] [Related]
10. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.
Vidaillac C; Guillon J; Arpin C; Forfar-Bares I; Ba BB; Grellet J; Moreau S; Caignard DH; Jarry C; Quentin C
Antimicrob Agents Chemother; 2007 Mar; 51(3):831-8. PubMed ID: 17101679
[TBL] [Abstract][Full Text] [Related]
12. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance.
Sabatini S; Gosetto F; Iraci N; Barreca ML; Massari S; Sancineto L; Manfroni G; Tabarrini O; Dimovska M; Kaatz GW; Cecchetti V
J Med Chem; 2013 Jun; 56(12):4975-89. PubMed ID: 23710549
[TBL] [Abstract][Full Text] [Related]
13. 1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors.
Hequet A; Burchak ON; Jeanty M; Guinchard X; Le Pihive E; Maigre L; Bouhours P; Schneider D; Maurin M; Paris JM; Denis JN; Jolivalt C
ChemMedChem; 2014 Jul; 9(7):1534-45. PubMed ID: 24677763
[TBL] [Abstract][Full Text] [Related]
14. Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
Sangwan PL; Koul JL; Koul S; Reddy MV; Thota N; Khan IA; Kumar A; Kalia NP; Qazi GN
Bioorg Med Chem; 2008 Nov; 16(22):9847-57. PubMed ID: 18848780
[TBL] [Abstract][Full Text] [Related]
15. Substituted dihydronaphthalenes as efflux pump inhibitors of Staphylococcus aureus.
Thota N; Reddy MV; Kumar A; Khan IA; Sangwan PL; Kalia NP; Koul JL; Koul S
Eur J Med Chem; 2010 Sep; 45(9):3607-16. PubMed ID: 20605275
[TBL] [Abstract][Full Text] [Related]
16. 1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus.
Naaz F; Khan A; Kumari A; Ali I; Ahmad F; Ahmad Lone B; Ahmad N; Ali Khan I; Rajput VS; Grover A; Shafi S
Bioorg Chem; 2021 Aug; 113():105031. PubMed ID: 34089943
[TBL] [Abstract][Full Text] [Related]
17. Amino acid amides of piperic acid (PA) and 4-ethylpiperic acid (EPA) as NorA efflux pump inhibitors of Staphylococcus aureus.
Wani NA; Singh S; Farooq S; Shankar S; Koul S; Khan IA; Rai R
Bioorg Med Chem Lett; 2016 Sep; 26(17):4174-8. PubMed ID: 27503686
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
Brincat JP; Carosati E; Sabatini S; Manfroni G; Fravolini A; Raygada JL; Patel D; Kaatz GW; Cruciani G
J Med Chem; 2011 Jan; 54(1):354-65. PubMed ID: 21141825
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.
Rath SK; Singh S; Kumar S; Wani NA; Rai R; Koul S; Khan IA; Sangwan PL
Bioorg Med Chem; 2019 Jan; 27(2):343-353. PubMed ID: 30552006
[TBL] [Abstract][Full Text] [Related]
20. Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor.
Zhang J; Sun Y; Wang Y; Lu M; He J; Liu J; Chen Q; Zhang X; Zhou F; Wang G; Sun X
Eur J Pharmacol; 2014 Oct; 740():277-84. PubMed ID: 25054686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
